rivaroxaban
bayer
['invictus', 'rivaroxaban']
invictus trial: in rhd-af, compared to rivaroxaban vkas reduced ischemic stroke and mortality, without increasing the risk of major bleeding! #esccongress #esc2022 #invictus #oldgoodvka 